Insider trading

Period: 120 months Stock: GYRE Type of trade: Bought × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

20 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

20 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

20 decisions over 120 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

20 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
20 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
20 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

20 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
9 Aug 2022
Blouse Grant E. Chief Scientific Officer
Bought
$1.53K 3,250 at 0.47
52.7%
+53% of stake
9 Aug 2022
Miller Seline E. SVP Finance; Interim CFO & PAO
Bought
$1.53K 3,250 at 0.47
100%
Largest buy in 3 yrs
9 Aug 2022
USMAN NASSIM President & CEO
Bought
$1.53K 3,250 at 0.47
15.3%
9 Feb 2022
Blouse Grant E. Chief Scientific Officer
Bought
$1.50K 3,250 at 0.46
111%
+111% of stake
9 Feb 2022
Miller Seline E. SVP Finance; Interim CFO & PAO
Bought
$1.50K 3,250 at 0.46
opened
First buy on file
9 Feb 2022
USMAN NASSIM President & CEO
Bought
$1.50K 3,250 at 0.46
18.0%
9 Aug 2021
Blouse Grant E. Chief Scientific Officer
Bought
$4.21K 1,163 at 3.62
66.3%
First buy on file
9 Aug 2021
USMAN NASSIM President & CEO
Bought
$3.14K 867 at 3.62
5.0%
Largest buy in 3 yrs
9 Aug 2021
Levy Howard Chief Medical Officer
Bought
$2.31K 639 at 3.62
opened
9 Feb 2021
Levy Howard Chief Medical Officer · indirect
Bought
$8.03K 1,670 at 4.81
7.7%
First buy on file
9 Feb 2021
USMAN NASSIM President & CEO
Bought
$2.80K 582 at 4.81
5.0%
First buy on file
10 Aug 2020
Levy Howard Chief Medical Officer
Bought
$8.50K 1,768 at 4.81
70.7%
First buy on file
10 Aug 2020
USMAN NASSIM President & CEO
Bought
$2.80K 582 at 4.81
5.3%
First buy on file
16 Mar 2020
Levy Howard Chief Medical Officer
Bought
$10.13K 2,500 at 4.05
opened
First buy on file
13 Mar 2020
USMAN NASSIM President & CEO
Bought
$15.65K 4,000 at 3.91
57.1%
First buy on file
13 Mar 2020
Richard John P Director
Bought
$9.95K 2,500 at 3.98
206%
First buy on file
13 Mar 2020
Cai Veronica Controller
Bought
$8.22K 2,000 at 4.11
37.4%
First buy on file
4 Mar 2020
Williams Eddie Director
Bought
$11.56K 2,000 at 5.78
22.6%
First buy on file
25 Feb 2020
Bought
$18.69K 3,000 at 6.23
opened
First buy on file
24 May 2019
Richard John P Director
Bought
$8.03K 1,000 at 8.03
463%
First buy on file
Showing 1–20 of 20.